Cryo Cell International (CCEL) Net Margin (2010 - 2026)

Cryo Cell International has disclosed Net Margin across 17 years of filings, most recently posting 0.61% for Q1 2026.

• In Q1 2026, Net Margin fell 294.0% year-over-year to 0.61%; the TTM figure through Feb 2026 stood at 8.52% (down 892.0% YoY), while the FY2025 annual figure was 7.7%, down 895.0% from the prior year.
• Net Margin advanced to 0.61% in Q1 2026, from 48.67% in the prior quarter.
• Over the last five years, Net Margin for CCEL reached as high as 13.04% in Q3 2024 and fell as low as 142.06% in Q4 2023.
• The 5-year median for Net Margin is 7.08% (2024), against an average of 6.44%.
• Annual changes were most pronounced in 2023 — Net Margin tumbled 15286 bps — and 2024, when it soared 11886 bps.
• A 5-year view of Net Margin shows it stood at 10.79% in 2022, then plunged by 1417 bps to 142.06% in 2023, then soared by 84 bps to 23.2% in 2024, then sank by 110 bps to 48.67% in 2025, then soared by 101 bps to 0.61% in 2026.
• According to Business Quant data, Net Margin over the past three periods registered 0.61%, 48.67%, and 9.58% for Q1 2026, Q4 2025, and Q3 2025 respectively.